Filter
272
Text search:
pharmacokinetics
Featured
Recommendations
31
New Publications
52
Language
Document type
No document type
144
Guidelines
56
Studies & Reports
39
Manuals
15
Fact sheets
6
Training Material
5
Strategic & Response Plan
5
Resource Platforms
1
Online Courses
1
Countries / Regions
India
13
Global
9
Ethiopia
7
South Africa
6
Russia
6
Uganda
4
Kenya
4
Latin America and the Carribbean
4
Zimbabwe
3
Rwanda
3
Argentina
3
Brazil
3
Ukraine
3
Western and Central Europe
3
Africa
3
Eastern Europe
3
Sierra Leone
2
Liberia
2
Cameroon
2
Germany
2
Zambia
2
Tanzania
2
Cambodia
2
Eswatini/ Swaziland
2
East and Southern Africa
2
Nigeria
1
Congo, Democratic Republic of
1
Ghana
1
Philippines
1
South Sudan
1
Syria
1
Thailand
1
Bangladesh
1
Mozambique
1
Sudan
1
Namibia
1
Botswana
1
Angola
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Authors & Publishers
Publication Years
Category
Countries
69
Clinical Guidelines
66
Women & Child Health
13
Public Health
10
Capacity Building
4
Pharmacy & Technologies
2
Key Resources
1
Toolboxes
TB
42
HIV
37
AMR
21
Mental Health
15
Pharmacy
15
NTDs
14
Malaria
11
Ebola & Marburg
10
COVID-19
8
Planetary Health
6
Refugee
4
Caregiver
4
NCDs
4
Disability
2
Rapid Response
2
Global Health Education
2
Polio
1
Conflict
1
Natural Hazards
1
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured patient training, and monitoring of blood glucose levels. The guidelines emphasize preventing complica
...
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces o
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med
...
First Revised Edition
March 2000
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘
...
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Towards a world free of tuberculosis
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
